Format

Send to

Choose Destination
BMC Psychiatry. 2013 May 16;13:140. doi: 10.1186/1471-244X-13-140.

Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis.

Author information

1
Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH, University of Aachen, Bergische Landstrasse 2, 40629 Düsseldorf, Germany. Zacharias.Laoutidis@lvr.de

Abstract

BACKGROUND:

Over the past thirty years a number of studies have suggested that antidepressants can be effective in the treatment of depressive symptoms in patients with cancer. The aim of this paper was to review randomized controlled trials (RCTs) and to perform a meta-analysis in order to quantify their overall effect.

METHODS:

Pubmed and the Cochrane libraries were searched for the time period between 1980 and 2010.

RESULTS:

Nine RCTs were identified and reviewed. Six of them (with a total of 563 patients) fulfilled the criteria for meta-analysis, but exhibited an unclear risk for bias. The estimated effect size was 1.56 with 95% CI: 1.07- 2.28 (p= 0.021). There were no differences in discontinuation rates between antidepressants and placebo groups (RR= 0.86 with 95% CI 0.47- 1.56, p=0.62).

CONCLUSIONS:

This meta-analysis suggests that antidepressants can be effective in treating depressive symptoms beside clinical depression. When considering the risk of side effects and interactions and the heterogeneity among the mostly small studies, a general recommendation cannot be made until well-controlled studies are conducted.

PMID:
23679841
PMCID:
PMC3674917
DOI:
10.1186/1471-244X-13-140
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center